Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Revenue

In the fiscal year ending March 31, 2026, Biogen Pharmachem Industries had annual revenue of 25.58M INR with 113.58% growth. Biogen Pharmachem Industries had revenue of 5.78M in the quarter ending March 31, 2026, a decrease of -66.22%.

• Revenue: 25.58M
• Revenue Growth: +113.58%
• P/S Ratio: 11.01
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 281.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.58M	13.60M	113.58%
Mar 31, 2025	11.98M	4.09M	51.78%
Mar 31, 2024	7.89M	5.39M	215.26%
Mar 31, 2023	2.50M	-22.31M	-89.91%
Mar 31, 2022	24.81M	8.58M	52.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error